Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of SY002 for dysmenorrhea
CTR20263238Phase 2Active
- Sponsor
- Jiacheng Biomedical
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine in dysmenorrhea, primary dysmenorrhea (PD), Secondary dysmenorrhea, sponsored by Jiacheng Biomedical. Started Sep 2026; status: active.
02
Drugs
ropivacaine
03
Conditions
dysmenorrheaprimary dysmenorrhea (PD)Secondary dysmenorrhea
Beyond the preview
Go deeper on CTR20263238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263238.